{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:35:29Z","timestamp":1791275729674,"version":"4.1.0"},"reference-count":83,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1253\/circj.cj-14-0621","type":"journal-article","created":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T19:14:09Z","timestamp":1404674049000},"page":"1775-1781","source":"Crossref","is-referenced-by-count":179,"title":["Macrophage Phenotypes and Their Modulation in Atherosclerosis"],"prefix":"10.1253","volume":"78","author":[{"given":"Federica","family":"De Paoli","sequence":"first","affiliation":[{"name":"Universit\u00e9 Lille 2"},{"name":"Inserm Lille"},{"name":"Institut Pasteur de Lille"},{"name":"European Genomic Institute for Diabetes (EGID)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Lille 2"},{"name":"Inserm Lille"},{"name":"Institut Pasteur de Lille"},{"name":"European Genomic Institute for Diabetes (EGID)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Chinetti-Gbaguidi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Lille 2"},{"name":"Inserm Lille"},{"name":"Institut Pasteur de Lille"},{"name":"European Genomic Institute for Diabetes (EGID)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. RossR.Atherosclerosis: An inflammatory disease.<i>N Engl J Med<\/i>1999;340:115\u2013126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. PorcherayF,ViaudS,RimaniolAC,LeoneC,SamahB,Dereuddre-BosquetN, et al.Macrophage activation switching: An asset for the resolution of inflammation.<i>Clin Exp Immunol<\/i>2005;142:481\u2013489.","DOI":"10.1111\/j.1365-2249.2005.02934.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. MantovaniA,GarlandaC,LocatiM.Macrophage diversity and polarization in atherosclerosis: A question of balance.<i>Arterioscler Thromb Vasc Biol<\/i>2009;29:1419\u20131423.","DOI":"10.1161\/ATVBAHA.108.180497"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. GordonS,MartinezFO.Alternative activation of macrophages: Mechanism and functions.<i>Immunity<\/i>2010;32:593\u2013604.","DOI":"10.1016\/j.immuni.2010.05.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. SteinM,KeshavS,HarrisN,GordonS.Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation.<i>J Exp Med<\/i>1992;176:287\u2013292.","DOI":"10.1084\/jem.176.1.287"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. MantovaniA,SicaA,SozzaniS,AllavenaP,VecchiA,LocatiM.The chemokine system in diverse forms of macrophage activation and polarization.<i>Trends Immunol<\/i>2004;25:677\u2013686.","DOI":"10.1016\/j.it.2004.09.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. MartinezFO,SicaA,MantovaniA,LocatiM.Macrophage activation and polarization.<i>Front Biosci<\/i>2008;13:453\u2013461.","DOI":"10.2741\/2692"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. ZizzoG,HilliardBA,MonestierM,CohenPL.Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.<i>J Immunol<\/i>2012;189:3508\u20133520.","DOI":"10.4049\/jimmunol.1200662"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pinhal-EnfieldG,RamanathanM,HaskoG,VogelSN,SalzmanAL,BoonsGJ, et al.An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.<i>Am J Pathol<\/i>2003;163:711\u2013721.","DOI":"10.1016\/S0002-9440(10)63698-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. FerranteCJ,Pinhal-EnfieldG,ElsonG,CronsteinBN,HaskoG,OutramS, et al.The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling.<i>Inflammation<\/i>2013;36:921\u2013931.","DOI":"10.1007\/s10753-013-9621-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. VerreckFA,de BoerT,LangenbergDM,HoeveMA,KramerM,VaisbergE, et al.Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.<i>Proc Natl Acad Sci USA<\/i>2004;101:4560\u20134565.","DOI":"10.1073\/pnas.0400983101"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. WaldoSW,LiY,BuonoC,ZhaoB,BillingsEM,ChangJ, et al.Heterogeneity of human macrophages in culture and in atherosclerotic plaques.<i>Am J Pathol<\/i>2008;172:1112\u20131126.","DOI":"10.2353\/ajpath.2008.070513"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. MartinezFO,GordonS,LocatiM,MantovaniA.Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression.<i>J Immunol<\/i>2006;177:7303\u20137311.","DOI":"10.4049\/jimmunol.177.10.7303"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. GleissnerCA,ShakedI,LittleKM,LeyK.CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.<i>J Immunol<\/i>2010;184:4810\u20134818.","DOI":"10.4049\/jimmunol.0901368"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. AdamsonS,LeitingerN.Phenotypic modulation of macrophages in response to plaque lipids.<i>Curr Opin Lipidol<\/i>2011;22:335\u2013342.","DOI":"10.1097\/MOL.0b013e32834a97e4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. BouhlelMA,DerudasB,RigamontiE,DievartR,BrozekJ,HaulonS, et al.PPARg activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.<i>Cell Metab<\/i>2007;6:137\u2013143.","DOI":"10.1016\/j.cmet.2007.06.010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chinetti-GbaguidiG,BaronM,BouhlelMA,VanhoutteJ,CopinC,SebtiY, et al.Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPAR\u03b3 and LXR\u03b1 pathways.<i>Circ Res<\/i>2011;108:985\u2013995.","DOI":"10.1161\/CIRCRESAHA.110.233775"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. BoyleJJ,HarringtonHA,PiperE,ElderfieldK,StarkJ,LandisRC, et al.Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.<i>Am J Pathol<\/i>2009;174:1097\u20131108.","DOI":"10.2353\/ajpath.2009.080431"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. BoyleJJ,JohnsM,KampferT,NguyenAT,GameL,SchaerDJ, et al.Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.<i>Circ Res<\/i>2012;110:20\u201333.","DOI":"10.1161\/CIRCRESAHA.111.247577"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. FinnAV,NakanoM,PolavarapuR,KarmaliV,SaeedO,ZhaoX, et al.Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.<i>J Am Coll Cardiol<\/i>2012;59:166\u2013177.","DOI":"10.1016\/j.jacc.2011.10.852"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. BoriesG,ColinS,VanhoutteJ,DerudasB,CopinC,FanchonM, et al.Liver X receptor (LXR) activation stimulates iron export in human alternative macrophages.<i>Circ Res<\/i>2013;113:1196\u20131205.","DOI":"10.1161\/CIRCRESAHA.113.301656"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. ErbelC,TykaM,HelmesCM,AkhavanpoorM,RuppG,DomschkeG, et al.CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7<sup>+<\/sup>S100A8<sup>+<\/sup> in vitro and in vivo.<i>Innate Immun<\/i> 2014 March 24, doi:10.1177\/1753425914526461.","DOI":"10.1177\/1753425914526461"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. GleissnerCA,ShakedI,ErbelC,BocklerD,KatusHA,LeyK.CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.<i>Circ Res<\/i>2010;106:203\u2013211.","DOI":"10.1161\/CIRCRESAHA.109.199505"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. KadlA,MeherAK,SharmaPR,LeeMY,DoranAC,JohnstoneSR, et al.Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.<i>Circ Res<\/i>2010;107:737\u2013746.","DOI":"10.1161\/CIRCRESAHA.109.215715"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Khallou-LaschetJ,VarthamanA,FornasaG,CompainC,GastonAT,ClementM, et al.Macrophage plasticity in experimental atherosclerosis.<i>PLoS One<\/i>2010;5:e8852, doi:10.1371\/journal.pone.0008852.","DOI":"10.1371\/journal.pone.0008852"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. BrocheriouI,MaoucheS,DurandH,BraunersreutherV,Le NaourG,GratchevA, et al.Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: Implication in atherosclerosis.<i>Atherosclerosis<\/i>2010;214:316\u2013324.","DOI":"10.1016\/j.atherosclerosis.2010.11.023"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. StogerJL,GijbelsMJ,van der VeldenS,MancaM,van der LoosCM,BiessenEA, et al.Distribution of macrophage polarization markers in human atherosclerosis.<i>Atherosclerosis<\/i>2012;225:461\u2013468.","DOI":"10.1016\/j.atherosclerosis.2012.09.013"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. ChoKY,MiyoshiH,KurodaS,YasudaH,KamiyamaK,NakagawaraJ, et al.The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery.<i>J Stroke Cerebrovasc Dis<\/i>2013;22:910\u2013918.","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.020"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. BartelDP.MicroRNAs: Target recognition and regulatory functions.<i>Cell<\/i>2009;136:215\u2013233.","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. ChendrimadaTP,GregoryRI,KumaraswamyE,NormanJ,CoochN,NishikuraK, et al.TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing.<i>Nature<\/i>2005;436:740\u2013744.","DOI":"10.1038\/nature03868"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Valencia-SanchezMA,LiuJ,HannonGJ,ParkerR.Control of translation and mRNA degradation by miRNAs and siRNAs.<i>Genes Dev<\/i>2006;20:515\u2013524.","DOI":"10.1101\/gad.1399806"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. O\u2019ConnellRM,RaoDS,ChaudhuriAA,BaltimoreD.Physiological and pathological roles for microRNAs in the immune system.<i>Nat Rev Immunol<\/i>2010;10:111\u2013122.","DOI":"10.1038\/nri2708"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. RaitoharjuE,LyytikainenLP,LevulaM,OksalaN,MennanderA,TarkkaM, et al.miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study.<i>Atherosclerosis<\/i>2011;219:211\u2013217.","DOI":"10.1016\/j.atherosclerosis.2011.07.020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. BidzhekovK,GanL,DeneckeB,RostalskyA,HristovM,KoeppelTA, et al.microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans.<i>Thromb Haemost<\/i>2012;107:619\u2013625.","DOI":"10.1160\/TH11-09-0607"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nazari-JahantighM,WeiY,NoelsH,AkhtarS,ZhouZ,KoenenRR, et al.MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.<i>J Clin Invest<\/i>2012;122:4190\u20134202.","DOI":"10.1172\/JCI61716"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. O\u2019ConnellRM,ChaudhuriAA,RaoDS,BaltimoreD.Inositol phosphatase SHIP1 is a primary target of miR-155.<i>Proc Natl Acad Sci USA<\/i>2009;106:7113\u20137118.","DOI":"10.1073\/pnas.0902636106"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. DonnersMM,WolfsIM,StogerLJ,Van der VorstEP,PottgensCC,HeymansS, et al.Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice.<i>PLoS One<\/i>2012;7:e35877, doi:10.1371\/journal.pone.0035877.","DOI":"10.1371\/journal.pone.0035877"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. CaiX,YinY,LiN,ZhuD,ZhangJ,ZhangCY, et al.Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155.<i>J Mol Cell Biol<\/i>2012;4:341\u2013343.","DOI":"10.1093\/jmcb\/mjs044"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. LiuG,FriggeriA,YangY,ParkYJ,TsurutaY,AbrahamE.miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.<i>Proc Natl Acad Sci USA<\/i>2009;106:15819\u201315824.","DOI":"10.1073\/pnas.0901216106"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. SheedyFJ,Palsson-McDermottE,HennessyEJ,MartinC,O\u2019LearyJJ,RuanQ, et al.Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.<i>Nat Immunol<\/i>2010;11:141\u2013147.","DOI":"10.1038\/ni.1828"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. TaganovKD,BoldinMP,ChangKJ,BaltimoreD.NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.<i>Proc Natl Acad Sci USA<\/i>2006;103:12481\u201312486.","DOI":"10.1073\/pnas.0605298103"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. AndroulidakiA,IliopoulosD,ArranzA,DoxakiC,SchworerS,ZacharioudakiV, et al.The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs.<i>Immunity<\/i>2009;31:220\u2013231.","DOI":"10.1016\/j.immuni.2009.06.024"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. ChaudhuriAA,SoAY,SinhaN,GibsonWS,TaganovKD,O\u2019ConnellRM, et al.MicroRNA-125b potentiates macrophage activation.<i>J Immunol<\/i>2011;187:5062\u20135068.","DOI":"10.4049\/jimmunol.1102001"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Gallardo-SolerA,Gomez-NietoC,CampoML,MaratheC,TontonozP,CastrilloA, et al.Arginase I induction by modified lipoproteins in macrophages: A peroxisome proliferator-activated receptor-gamma\/delta-mediated effect that links lipid metabolism and immunity.<i>Mol Endocrinol<\/i>2008;22:1394\u20131402.","DOI":"10.1210\/me.2007-0525"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. BouhlelMA,BrozekJ,DerudasB,ZawadzkiC,JudeB,StaelsB, et al.Unlike PPARgamma, PPARalpha or PPARbeta\/delta activation does not promote human monocyte differentiation toward alternative macrophages.<i>Biochem Biophys Res Commun<\/i>2009;386:459\u2013462.","DOI":"10.1016\/j.bbrc.2009.06.047"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. KangK,ReillySM,KarabacakV,GanglMR,FitzgeraldK,HatanoB, et al.Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity.<i>Cell Metab<\/i>2008;7:485\u2013495.","DOI":"10.1016\/j.cmet.2008.04.002"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. OdegaardJI,Ricardo-GonzalezRR,Red EagleA,VatsD,MorelCR,GoforthMH, et al.Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.<i>Cell Metab<\/i>2008;7:496\u2013507.","DOI":"10.1016\/j.cmet.2008.04.003"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. PrieurX,MokCY,VelagapudiVR,NunezV,FuentesL,MontanerD, et al.Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2\/M1 polarization in obese mice.<i>Diabetes<\/i>2011;60:797\u2013809.","DOI":"10.2337\/db10-0705"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. StienstraR,DuvalC,KeshtkarS,van der LaakJ,KerstenS,MullerM.Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.<i>J Biol Chem<\/i>2008;283:22620\u201322627.","DOI":"10.1074\/jbc.M710314200"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. LiaoX,SharmaN,KapadiaF,ZhouG,LuY,HongH, et al.Kruppel-like factor 4 regulates macrophage polarization.<i>J Clin Invest<\/i>2011;121:2736\u20132749.","DOI":"10.1172\/JCI45444"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. DateD,DasR,NarlaG,SimonDI,JainMK,MahabeleshwarGH.Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization.<i>J Biol Chem<\/i>2014;289:10318\u201310329.","DOI":"10.1074\/jbc.M113.526749"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. PourcetB,FeigJE,VengrenyukY,HobbsAJ,Kepka-LenhartD,GarabedianMJ, et al.LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.<i>Circ Res<\/i>2011;109:492\u2013501.","DOI":"10.1161\/CIRCRESAHA.111.241810"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. MaH,ZhongW,JiangY,FontaineC,LiS,FuJ, et al.Increased atherosclerotic lesions in LDL receptor deficient mice with hematopoietic nuclear receptor Rev-erb\u03b1 knock- down.<i>J Am Heart Assoc<\/i>2013;2:e000235, doi:10.1161\/JAHA.113.000235.","DOI":"10.1161\/JAHA.113.000235"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. HannaRN,CarlinLM,HubbelingHG,NackiewiczD,GreenAM,PuntJA, et al.The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes.<i>Nat Immunol<\/i>2011;12:778\u2013785.","DOI":"10.1038\/ni.2063"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. HamersAA,VosM,RassamF,MarinkovicG,KurakulaK,van GorpPJ, et al.Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis.<i>Circ Res<\/i>2012;110:428\u2013438.","DOI":"10.1161\/CIRCRESAHA.111.260760"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. HannaRN,ShakedI,HubbelingHG,PuntJA,WuR,HerrleyE, et al.NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis.<i>Circ Res<\/i>2012;110:416\u2013427.","DOI":"10.1161\/CIRCRESAHA.111.253377"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. ChaoLC,SotoE,HongC,ItoA,PeiL,ChawlaA, et al.Bone marrow NR4A expression is not a dominant factor in the development of atherosclerosis or macrophage polarization in mice.<i>J Lipid Res<\/i>2013;54:806\u2013815.","DOI":"10.1194\/jlr.M034157"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. MurphyE.Estrogen signaling and cardiovascular disease.<i>Circ Res<\/i>;109:687\u2013696.","DOI":"10.1161\/CIRCRESAHA.110.236687"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. RibasV,DrewBG,LeJA,SoleymaniT,DaraeiP,SitzD, et al.Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.<i>Proc Natl Acad Sci USA<\/i>2011;108:16457\u201316462.","DOI":"10.1073\/pnas.1104533108"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. RaderDJ.Molecular regulation of HDL metabolism and function: Implications for novel therapies.<i>J Clin Invest<\/i>2006;116:3090\u20133100.","DOI":"10.1172\/JCI30163"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. CockerillGW,RyeKA,GambleJR,VadasMA,BarterPJ.High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.<i>Arterioscler Thromb Vasc Biol<\/i>1995;15:1987\u20131994.","DOI":"10.1161\/01.ATV.15.11.1987"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. FeigJE,RongJX,ShamirR,SansonM,VengrenyukY,LiuJ, et al.HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.<i>Proc Natl Acad Sci USA<\/i>2011;108:7166\u20137171.","DOI":"10.1073\/pnas.1016086108"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. SansonM,DistelE,FisherEA.HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process.<i>PLoS One<\/i>2013;8:e74676, doi:10.1371\/journal.pone.0074676.","DOI":"10.1371\/journal.pone.0074676"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. ColinS,FanchonM,BelloyL,BochemAE,CopinC,DerudasB, et al.HDL does not influence the polarization of human monocytes toward an alternative phenotype.<i>Int J Cardiol<\/i>2014;172:179\u2013184.","DOI":"10.1016\/j.ijcard.2013.12.168"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. YamawakiH,HaendelerJ,BerkBC.Thioredoxin: A key regulator of cardiovascular homeostasis.<i>Circ Res<\/i>2003;93:1029\u20131033.","DOI":"10.1161\/01.RES.0000102869.39150.23"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. HolmgrenA,LuJ.Thioredoxin and thioredoxin reductase: Current research with special reference to human disease.<i>Biochem Biophys Res Commun<\/i>2010;396:120\u2013124.","DOI":"10.1016\/j.bbrc.2010.03.083"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. El HadriK,MahmoodDF,CouchieD,Jguirim-SouissiI,GenzeF,DiderotV, et al.Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.<i>Arterioscler Thromb Vasc Biol<\/i>2012;32:1445\u20131452.","DOI":"10.1161\/ATVBAHA.112.249334"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. MahmoodDF,AbderrazakA,CouchieD,LunovO,DiderotV,SyrovetsT, et al.Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis.<i>J Cell Physiol<\/i>2013;228:1577\u20131583.","DOI":"10.1002\/jcp.24319"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.28.721"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. TeradaN,LucasJJ,SzepesiA,FranklinRA,DomenicoJ,GelfandEW.Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.<i>J Cell Physiol<\/i>1993;154:7\u201315.","DOI":"10.1002\/jcp.1041540103"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. InokiK,CorradettiMN,GuanKL.Dysregulation of the TSC-mTOR pathway in human disease.<i>Nat Genet<\/i>2005;37:19\u201324.","DOI":"10.1038\/ng1494"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. MercalliA,SordiV,PonzoniM,MaffiP,De TaddeoF,GattiG, et al.Rapamycin induces a caspase-independent cell death in human monocytes.<i>Am J Transplant<\/i>2006;6:1331\u20131341.","DOI":"10.1111\/j.1600-6143.2006.01332.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. WeichhartT,CostantinoG,PoglitschM,RosnerM,ZeydaM,StuhlmeierKM, et al.The TSC-mTOR signaling pathway regulates the innate inflammatory response.<i>Immunity<\/i>2008;29:565\u2013577.","DOI":"10.1016\/j.immuni.2008.08.012"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. MercalliA,CalavitaI,DugnaniE,CitroA,CantarelliE,NanoR, et al.Rapamycin unbalances the polarization of human macrophages to M1.<i>Immunology<\/i>2013;140:179\u2013190.","DOI":"10.1111\/imm.12126"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. BylesV,CovarrubiasAJ,Ben-SahraI,LammingDW,SabatiniDM,ManningBD, et al.The TSC-mTOR pathway regulates macrophage polarization.<i>Nat Commun<\/i>2013;4:2834.","DOI":"10.1038\/ncomms3834"},{"key":"76","unstructured":"76. Assaad-KhalilSH,LachineN,SidrakM,AmaraF,JacototB,FahmyMH.Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis.<i>Ann Biol Clin (Paris)<\/i>1992;50:697\u2013701."},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. CudejkoC,WoutersK,FuentesL,HannouSA,PaquetC,BantubungiK, et al.p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.<i>Blood<\/i>2011;118:2556\u20132566.","DOI":"10.1182\/blood-2010-10-313106"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. WolfsIM,StogerJL,GoossensP,PottgensC,GijbelsMJ,WijnandsE, et al.Reprogramming macrophages to an anti-inflammatory phenotype by helminth antigens reduces murine atherosclerosis.<i>Faseb J<\/i>2014;28:288\u2013299.","DOI":"10.1096\/fj.13-235911"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. AdamsMJ,HardenberghPH,ConstineLS,LipshultzSE.Radiation-associated cardiovascular disease.<i>Crit Rev Oncol Hematol<\/i>2003;45:55\u201375.","DOI":"10.1016\/S1040-8428(01)00227-X"},{"key":"80","unstructured":"80. DarbySC,CutterDJ,BoermaM,ConstineLS,FajardoLF,KodamaK, et al.Radiation-related heart disease: Current knowledge and future prospects.<i>Int J Radiat Oncol Biol Phys<\/i>2010;76:656\u2013665."},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. HovingS,HeenemanS,GijbelsMJ,te PoeleJA,RussellNS,DaemenMJ, et al.Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(\u2013\/\u2013) mice.<i>Int J Radiat Oncol Biol Phys<\/i>2008;71:848\u2013857.","DOI":"10.1016\/j.ijrobp.2008.02.031"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. StewartFA,HeenemanS,Te PoeleJ,KruseJ,RussellNS,GijbelsM, et al.Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE<sup>\u2013\/\u2013<\/sup> mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.<i>Am J Pathol<\/i>2006;168:649\u2013658.","DOI":"10.2353\/ajpath.2006.050409"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. GabrielsK,HovingS,GijbelsMJ,PolJF,Te PoeleJA,BiessenEA, et al.Irradiation of existing atherosclerotic lesions increased inflammation by favoring pro-inflammatory macrophages.<i>Radiother Oncol<\/i>2014;110:455\u2013460.","DOI":"10.1016\/j.radonc.2014.01.006"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/8\/78_CJ-14-0621\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T11:00:28Z","timestamp":1649588428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/78\/8\/78_CJ-14-0621\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-0621","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}